Abstract
Objectives
To describe a cohort of bilateral stone formers with significantly different compositions between renal units.
Methods
Patients treated for bilateral nephrolithiasis over a 4-year period (2007–2010) were identified. Stones were categorized by dominant (≥50 %) mineralogical component. Patients with significant compositional differences between renal units (discordant stone formers) were compared to patients with a similar stone type in each kidney.
Results
Fifteen of the 59 bilateral stone formers (25.4 %) were discordant stone formers with significant differences in stone composition between renal units. Forty-four of the 59 patients (74.6 %) had the same stone composition on each side. Thirty percent of discordant stones had calcium phosphate as the dominant stone component. Discordant stone formers were younger, had better renal function, and tended to have a larger stone burden (p < 0.05).
Conclusions
A significant minority of bilateral stone formers form a different type of stone in each kidney. Local or micro-environmental etiologies may explain this phenomenon and may also account for failure of preventive therapy in some patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Long LO, Park S (2007) Update on nephrolithiasis management. Minerva Urol Nefrol 59:317–325
Kourambas J, Aslan P, Teh CL, Mathias BJ, Preminger GM (2001) Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis. J Endourol 15:181–186
Saita A, Bonaccorsi A, Motta M (2007) Stone composition: where do we stand? Urol Int 79(Suppl 1):16–19
Porena M, Guiggi P, Micheli C (2007) Prevention of stone disease. Urol Int 79(Suppl 1):37–46
Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65:386–392
Asplin JR (2009) Obesity and urolithiasis. Adv Chronic Kidney Dis 16:11–20
Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F, Novarini A (1999) Essential arterial hypertension and stone disease. Kidney Int 55:2397–2406
Gorbachinsky I, Akpinar H, Assimos DG (2010) Metabolic syndrome and urologic diseases. Rev Urol 12:e157–e180
Hammarsten J, Peeker R (2011) Urological aspects of the metabolic syndrome. Nat Rev Urol
West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis 51:741–747
Lee YH, Huang WC, Tsai JY, Huang JK (1999) The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm followup study. J Urol 161:1453–1457
Evan A, Lingeman J, Coe FL, Worcester E (2006) Randall’s plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69:1313–1318
Evan AP, Lingeman JE, Coe FL, Bledsoe SB, Sommer AJ, Williams JC Jr, Krambeck AE, Worcester EM (2009) Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int 76:1081–1088
Shafik A, El Sibai O, Shafik AA, Ahmed I (2004) Do vesical and voided urine have identical compositions? Scand J Urol Nephrol 38:243–246
Shafik A, Shafik I, El Sibai O, Shafik AA (2005) Changes in the urine composition during its passage through the ureter. A concept of urothelial function. Urol Res 33:426–428
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kadlec, A.O., Fridirici, Z.C., Acosta-Miranda, A.M. et al. Bilateral urinary calculi with discordant stone composition. World J Urol 32, 281–285 (2014). https://doi.org/10.1007/s00345-013-1113-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-013-1113-4